Author

Jennifer B. Nelson

University of ChicagoORCID 0000-0002-9244-4420Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Organism:mouse· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

Advaita Chakraborty· 1 shared Charanya MuralidharaniD· 1 shared David J. MaloneyiD· 1 shared Jacob R. EnriqueziD· 1 shared Jerry L. NadleriD· 1 shared Jiayi E. Wang· 1 shared Kayla T. Figatner· 1 shared Kerim B. KaylaniD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMolecular Biology

Advaita Chakraborty

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

12-Lipoxygenase inhibition delays onset of autoimmune diabetes in human gene replacement mice

Titli Nargis, Charanya Muralidharan, Jacob R. Enriquez, Jiayi E. Wang, Kerim B. Kaylan, Advaita Chakraborty, Sarida Pratuangtham, Kayla T. Figatner, Jennifer B. Nelson, Sarah C. May, Jerry L. Nadler, Matthew B. Boxer, David J. Maloney, Sarah A. Tersey, Raghavendra G. Mirmira

This study shows that inhibiting 12-LOX with VLX-1005 delays autoimmune diabetes onset in human gene replacement mice by altering inflammatory pathways and immune cell infiltration.

JCI Insight · Nov 12, 2024Peer-reviewedMolecular Biology